According to Truist Securities, the prior rating for Amedisys Inc (NASDAQ:AMED) was changed from Buy to Hold. For the first quarter, Amedisys had an EPS of $1.00, compared to year-ago quarter EPS of $1.23. The current stock performance of Amedisys shows a 52-week-high of $131.28 and a 52-week-low of $69.36. Moreover, at the end of the last trading period, the closing price was at $92.37.

According to HC Wainwright & Co., the prior rating for Check-Cap Ltd (NASDAQ:CHEK) was changed from Buy to Neutral. In the first quarter, Check-Cap showed an EPS of $0.76, compared to $1.13 from the year-ago quarter. The current stock performance of Check-Cap shows a 52-week-high of $9.20 and a 52-week-low of $1.22. Moreover, at the end of the last trading period, the closing price was at $1.95.

For Paratek Pharmaceuticals Inc (NASDAQ:PRTK), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the first quarter, Paratek Pharmaceuticals showed an EPS of $0.35, compared to $0.35 from the year-ago quarter. The current stock performance of Paratek Pharmaceuticals shows a 52-week-high of $3.65 and a 52-week-low of $1.29. Moreover, at the end of the last trading period, the closing price was at $2.17.

For Staar Surgical Co (NASDAQ:STAA), William Blair downgraded the previous rating of Outperform to Market Perform. In the first quarter, Staar Surgical showed an EPS of $0.18, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $112.23 and a 52-week-low of $46.41. Staar Surgical closed at $54.79 at the end of the last trading period.

According to Oppenheimer, the prior rating for Chemomab Therapeutics Ltd (NASDAQ:CMMB) was changed from Outperform to Perform. For the first quarter, Chemomab Therapeutics had an EPS of $0.80, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $5.35 and a 52-week-low of $1.38. At the end of the last trading period, Chemomab Therapeutics closed at $1.72.

According to Jefferies, the prior rating for Paratek Pharmaceuticals Inc (NASDAQ:PRTK) was changed from Buy to Hold. In the first quarter, Paratek Pharmaceuticals showed an EPS of $0.35, compared to $0.35 from the year-ago quarter. The current stock performance of Paratek Pharmaceuticals shows a 52-week-high of $3.65 and a 52-week-low of $1.29. Moreover, at the end of the last trading period, the closing price was at $2.17.

According to JMP Securities, the prior rating for Duolingo Inc (NASDAQ:DUOL) was changed from Market Outperform to Market Perform. For the first quarter, Duolingo had an EPS of $0.06, compared to year-ago quarter EPS of $0.31. The current stock performance of Duolingo shows a 52-week-high of $168.40 and a 52-week-low of $64.73. Moreover, at the end of the last trading period, the closing price was at $167.05.

For Integral Ad Science Holding Corp (NASDAQ:IAS), Benchmark initiated coverage, by setting the current rating at Hold. For the first quarter, Integral Ad Science had an EPS of $0.02, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $19.44 and a 52-week-low of $6.64. At the end of the last trading period, Integral Ad Science closed at $19.19.

With a Sell rating, Odeon Capital initiated coverage on Bank of Hawaii Corp (NYSE:BOH). The price target seems to have been set at $31.00 for Bank of Hawaii. In the first quarter, Bank of Hawaii showed an EPS of $1.14, compared to $1.32 from the year-ago quarter. At the moment, the stock has a 52-week-high of $85.38 and a 52-week-low of $30.83. Bank of Hawaii closed at $44.88 at the end of the last trading period.

Canaccord Genuity initiated coverage on Mobileye Global Inc (NASDAQ:MBLY) with a Buy rating. The price target for Mobileye Global is set to $50.00. Mobileye Global earned $0.14 in the first quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Mobileye Global shows a 52-week-high of $48.11 and a 52-week-low of $24.86. Moreover, at the end of the last trading period, the closing price was at $42.32.

With a Buy rating, Canaccord Genuity initiated coverage on Aurora Innovation Inc (NASDAQ:AUR). The price target seems to have been set at $5.00 for Aurora Innovation. Aurora Innovation earned $0.17 in the first quarter, compared to $0.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.29 and a 52-week-low of $1.10. Aurora Innovation closed at $1.52 at the end of the last trading period.

Raymond James initiated coverage on Reinsurance Group of America Inc (NYSE:RGA) with a Strong Buy rating. The price target for Reinsurance Gr is set to $199.00. In the first quarter, Reinsurance Gr showed an EPS of $5.16, compared to $0.47 from the year-ago quarter. The current stock performance of Reinsurance Gr shows a 52-week-high of $153.35 and a 52-week-low of $109.11. Moreover, at the end of the last trading period, the closing price was at $142.70.

With a Buy rating, HC Wainwright & Co. initiated coverage on Disc Medicine Inc (NASDAQ:IRON). The price target seems to have been set at $55.00 for Disc Medicine. Disc Medicine earned $1.20 in the first quarter, compared to $10.67 in the year-ago quarter. The current stock performance of Disc Medicine shows a 52-week-high of $211.50 and a 52-week-low of $13.50. Moreover, at the end of the last trading period, the closing price was at $39.17.

With a Buy rating, Jefferies initiated coverage on Terns Pharmaceuticals Inc (NASDAQ:TERN). The price target seems to have been set at $18.00 for Terns Pharma. Terns Pharma earned $0.31 in the first quarter, compared to $0.55 in the year-ago quarter. The current stock performance of Terns Pharma shows a 52-week-high of $14.04 and a 52-week-low of $1.70. Moreover, at the end of the last trading period, the closing price was at $11.63.

With a Neutral rating, Mizuho initiated coverage on Herbalife Ltd (NYSE:HLF). The price target seems to have been set at $13.00 for Herbalife. For the first quarter, Herbalife had an EPS of $0.54, compared to year-ago quarter EPS of $0.99. At the moment, the stock has a 52-week-high of $30.65 and a 52-week-low of $11.14. Herbalife closed at $12.25 at the end of the last trading period.

Rosenblatt initiated coverage on Super Micro Computer Inc (NASDAQ:SMCI) with a Buy rating. The price target for Super Micro Computer is set to $300.00. For the third quarter, Super Micro Computer had an EPS of $1.63, compared to year-ago quarter EPS of $1.55. The stock has a 52-week-high of $242.99 and a 52-week-low of $37.04. At the end of the last trading period, Super Micro Computer closed at $233.15.